Literature DB >> 7876159

Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation.

S S Rao1, D S Kohtz.   

Abstract

Differentiation of skeletal myoblasts in culture is negatively regulated by certain growth factors, including basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF beta). We investigated the effects of bFGF and TGF beta on D-type cyclin expression in skeletal myoblasts. When myoblasts were induced to differentiate in low mitogen medium, expression of cyclin D1 rapidly fell below detectable levels. In contrast, expression of cyclin D3 increased to levels exceeding those present in myoblasts. Expression of cyclin D1 was induced in myoblasts by bFGF and TGF beta (albeit with different kinetics for each factor), while induction of cyclin D3 expression was inhibited by these growth factors. Although these results are consistent with other reports showing induction of cyclin D1 by growth factors, induction of cyclin D3 expression during terminal differentiation of myoblasts and inhibition of this induction by growth factors is surprising. These results suggest that cyclin D3, previously thought to be only a positive regulator of cell cycle progression, may also function in the cellular context of terminal differentiated muscle. Stable expression of cyclin D1 from an ectopic viral promoter inhibits C2C12 myoblast differentiation, but only in those clones where the level of cyclin D1 expression does not significantly exceed that present in control myoblasts stimulated by bFGF. Together, these result suggest that cyclin D1 expression functions in the inhibition of myoblast differentiation by certain growth factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876159     DOI: 10.1074/jbc.270.8.4093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation.

Authors:  M C Moschella; K Menzies; L Tsao; M A Lieb; J D Kohtz; D S Kohtz; M B Taubman
Journal:  Gene Expr       Date:  1999

Review 2.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

3.  The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD.

Authors:  Z Yablonka-Reuveni; M A Rudnicki; A J Rivera; M Primig; J E Anderson; P Natanson
Journal:  Dev Biol       Date:  1999-06-15       Impact factor: 3.582

4.  Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.

Authors:  Jean-Bernard Lazaro; Peter J Bailey; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

Review 5.  Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.

Authors:  Serge Ostrovidov; Vahid Hosseini; Samad Ahadian; Toshinori Fujie; Selvakumar Prakash Parthiban; Murugan Ramalingam; Hojae Bae; Hirokazu Kaji; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2014-02-24       Impact factor: 6.389

6.  Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.

Authors:  D Tedesco; L Baron; L Fischer-Fantuzzi; C Vesco
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus.

Authors:  Hyun-Jung Kim; Eric Archer; Norma Escobedo; Stephen J Tapscott; Graciela A Unguez
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

8.  Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis.

Authors:  R U Jänicke; X Y Lin; F H Lee; A G Porter
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit.

Authors:  R M Zwijsen; R Klompmaker; E B Wientjens; P M Kristel; B van der Burg; R J Michalides
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration.

Authors:  Michael V Khanjyan; Jonathan Yang; Refik Kayali; Thomas Caldwell; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2013-04-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.